DNAJC5 and ovarian carcinoma: Here, we generated and characterized a novel CSP-targeting antibody, 1H11, evaluated its therapeutic efficacy as a monotherapy and in combination with chemotherapy, as well as investigated 1H11′s anticancer mechanism in ovarian cancer.